| Market Cap | 15.9B |
| Market Cap (USD) | $2.2B |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | 1.21 |
| Dividend Yield | - |
| D/E Ratio | 0.25 |
| Current Ratio | 2.27 |
| Market Segment | Main Board |
| Currency | CNY |
Business Overview
Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers, dialysis machines, hemodialysis machines, A.V. fistula needle sets, extracorporeal blood circuits, bloodlines, and plasma separators; peritoneal dialysis (PD) solutions; and PD consumables, such as bag free set, catheter joints, and transfer tube sets. The company was founded in 2004 and is based in Weihai, China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | C35专用设备制造业 |
| Market Segment | Main Board |
| Currency | CNY |
| Fiscal Year | 2024 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 威高血净 |
| Ticker | 603014 |
| Exchange | SSE |
| Sector | 证监会行业分类 |
| Industry | C35专用设备制造业 |
| Market Segment | Main Board |
| Fiscal Year | 2024 |
| Currency | CNY |
| Market Cap | 15.9B |
| Market Cap (USD) | $2.2B |
| Revenue | 3.6B |
| Net Income | 449.0M |
| P/E Ratio | - |
| EPS | 1.21 |
| Net Margin | 12.5% |
| ROE | 8.0% |
| Dividend Yield | - |
Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers, dialysis machines, hemodialysis machines, A.V. fistula needle sets, extracorporeal blood circuits, bloodlines, and plasma separators; peritoneal dialysis (PD) solutions; and PD consumables, such as bag free set, catheter joints, and transfer tube sets. The company was founded in 2004 and is based in Weihai, China.